Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
Quoin Pharmaceuticals released the latest episode of its NETHERTON NOW video series, Aminah's Story, told by Dr. Laura Wright-Sexton, the pediatric critical care physician who adopted Aminah after first treating her as a critically ill 10-month-old in her ICU. NETHERTON NOW, launched by Quoin in February 2025, is an awareness campaign for Netherton Syndrome, a rare inherited skin disease with no FDA-approved therapies. The release contains no new clinical or financial data; it reiterates that lead product QRX003 is in a Phase 2/3 trial for Netherton Syndrome and points to positive interim clinical data released Aug.
Key figures
- Drug Name
- QRX003
- Phase Of Trial
- Phase 2/3
- Campaign launch
- February 2025
- Qrx003 formulation
- topical serine protease inhibitor lotion (4%)
- Prior interim data release
- Aug. 28, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.